MLICM
DOVA

Metropolitan Life Insurance Company (MetLife)’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,264
Closed -$89.4K – 2602
2018
Q3 		$89.4K Hold
4,264
– – ﹤0.01% 2499
2018
Q2 		$128K Buy
+4,264
New +$116K ﹤0.01% 2206

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s DOVA Position: Q4 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2018, closing a stake of 4,264 shares — an estimated $89.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DOVA in Q2 2018 and held it in 2 quarters. The position peaked at $128K in Q2 2018. 58 funds tracked by Wall St. Rank hold DOVA as of Q4 2018.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,264 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2018, an estimated $89.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Dova Pharmaceuticals, Inc. Common Stock position peaked at $128K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2018, filed 14 Feb 2019.